| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Passage Bio Inc (NASDAQ: PASG)
PASG Technical Analysis
5
| As on 11th Jun 2025 PASG STOCK Price closed @ 0.46 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.99 & Strong Sell for SHORT-TERM with Stoploss of 1.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PASGSTOCK Price
| Open | 0.48 | Change | Price | % |
| High | 0.48 | 1 Day | -0.02 | -4.17 |
| Low | 0.44 | 1 Week | 0.02 | 4.55 |
| Close | 0.46 | 1 Month | 0.15 | 48.39 |
| Volume | 57450 | 1 Year | -0.45 | -49.45 |
| 52 Week High 1.73 | 52 Week Low 0.27 | ||||
NASDAQ USA Most Active Stocks
| HCTI | 0.01 | 0.00% |
| NCNA | 0.16 | 14.29% |
| AMRS | 0.14 | 100.00% |
| NUWE | 0.37 | 60.87% |
| GNLN | 0.01 | 0.00% |
| NVDA | 142.83 | -0.78% |
| HSDT | 1.11 | 32.14% |
| INTC | 20.68 | -6.34% |
| PLUG | 1.38 | 7.81% |
| QUBT | 18.97 | 25.38% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PASG Daily Charts |
PASG Intraday Charts |
Whats New @ Bazaartrend |
PASG Free Analysis |
|
|
PASG Important Levels Intraday
| RESISTANCE | 0.54 |
| RESISTANCE | 0.51 |
| RESISTANCE | 0.50 |
| RESISTANCE | 0.48 |
| SUPPORT | 0.44 |
| SUPPORT | 0.42 |
| SUPPORT | 0.41 |
| SUPPORT | 0.38 |
PASG Forecast June 2025
| 4th UP Forecast | 1.42 |
| 3rd UP Forecast | 1.11 |
| 2nd UP Forecast | 0.92 |
| 1st UP Forecast | 0.73 |
| 1st DOWN Forecast | 0.19 |
| 2nd DOWN Forecast | -0 |
| 3rd DOWN Forecast | -0.19 |
| 4th DOWN Forecast | -0.5 |
PASG Weekly Forecast
| 4th UP Forecast | 0.86 |
| 3rd UP Forecast | 0.73 |
| 2nd UP Forecast | 0.65 |
| 1st UP Forecast | 0.57 |
| 1st DOWN Forecast | 0.35 |
| 2nd DOWN Forecast | 0.27 |
| 3rd DOWN Forecast | 0.19 |
| 4th DOWN Forecast | 0.06 |
PASG Forecast2025
| 4th UP Forecast | 3.41 |
| 3rd UP Forecast | 2.46 |
| 2nd UP Forecast | 1.88 |
| 1st UP Forecast | 1.29 |
| 1st DOWN Forecast | -0.37 |
| 2nd DOWN Forecast | -0.96 |
| 3rd DOWN Forecast | -1.54 |
| 4th DOWN Forecast | -2.49 |
Passage Bio Inc ( NASDAQ USA Symbol : PASG )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PASG Business Profile
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase (ß-gal) for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin, or GRN, gene encoding progranulin, or PGRN, for the treatment of FTD-GRN; and PBKR03, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and PBCM06 for the treatment of Charcot-Marie-Tooth Type 2A, as well as programs for the treatment of adult CNS indication. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Address: Two Commerce Square, Philadelphia, PA, United States, 19103
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service